ZBTB6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.660130E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.316800E-01
Normal-vs-Stage2
1.164020E-02
Normal-vs-Stage3
1.598050E-01
Normal-vs-Stage4
6.349200E-01
Stage1-vs-Stage2
3.761400E-01
Stage1-vs-Stage3
4.417900E-02
Stage1-vs-Stage4
5.565600E-01
Stage2-vs-Stage3
2.438700E-03
Stage2-vs-Stage4
9.572400E-02
Stage3-vs-Stage4
1.505950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.298460E-02
Normal-vs-AfricanAmerican
2.446000E-01
Normal-vs-Asian
6.427700E-02
Caucasian-vs-AfricanAmerican
5.210000E-01
Caucasian-vs-Asian
9.576800E-01
AfricanAmerican-vs-Asian
6.318000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.438330E-02
Normal-vs-Female
2.964400E-02
Male-vs-Female
2.444800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.821200E-01
Normal-vs-Age(41-60Yrs)
7.605800E-02
Normal-vs-Age(61-80Yrs)
1.140230E-02
Normal-vs-Age(81-100Yrs)
2.147800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.434600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.958800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.980600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.163670E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.171900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.166800E-01
Normal-vs-Daily Drinker
2.012800E-01
Normal-vs-Weekly Drinker
1.575690E-02
Normal-vs-Occasional Drinker
1.582970E-01
Normal-vs-Social Drinker
1.452580E-01
Non Drinker-vs-Daily Drinker
6.596200E-01
Non Drinker-vs-Weekly Drinker
8.087000E-01
Non Drinker-vs-Occasional Drinker
3.482000E-02
Non Drinker-vs-Social Drinker
3.344100E-02
Daily Drinker-vs-Weekly Drinker
5.508600E-01
Daily Drinker-vs-Occasional Drinker
2.437900E-02
Daily Drinker-vs-Social Drinker
2.160000E-02
Weekly Drinker-vs-Occasional Drinker
1.377610E-01
Weekly Drinker-vs-Social Drinker
1.237570E-01
Occasional Drinker-vs-Social Drinker
9.930800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.560300E-02
Normal-vs-Grade 2
2.605800E-02
Normal-vs-Grade 3
3.216100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.916800E-01
Grade 1-vs-Grade 3
8.139400E-01
Grade 1-vs-Grade 4
7.560300E-02
Grade 2-vs-Grade 3
9.933800E-01
Grade 2-vs-Grade 4
2.605800E-02
Grade 3-vs-Grade 4
3.216100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.124350E-02
Normal-vs-NonDiabetic
1.168400E-02
Diabetic-vs-NonDiabetic
4.242600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.917900E-03
Normal-vs-NoPancreatitis
1.458420E-02
Pancreatitis-vs-NoPancreatitis
1.385390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.575500E-02
Normal-vs-N1
1.216460E-02
N0-vs-N1
6.213000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.050650E-01
Normal-vs-TP53-NonMutant
4.105400E-01
TP53-Mutant-vs-TP53-NonMutant
5.871600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
